GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $531,000 | +101.9% | 15,177 | +149.9% | 0.05% | +85.7% |
| Q4 2020 | $263,000 | -24.4% | 6,074 | -3.8% | 0.03% | -53.3% |
| Q3 2020 | $348,000 | -42.7% | 6,316 | -34.3% | 0.06% | -14.3% |
| Q2 2020 | $607,000 | +37.6% | 9,612 | +73.3% | 0.07% | +62.8% |
| Q4 2019 | $441,000 | -8.7% | 5,548 | -44.3% | 0.04% | +13.2% |
| Q3 2019 | $483,000 | -46.6% | 9,959 | -42.1% | 0.04% | -28.3% |
| Q2 2019 | $905,000 | +266.4% | 17,206 | +268.1% | 0.05% | +278.6% |
| Q1 2019 | $247,000 | -73.2% | 4,674 | -80.7% | 0.01% | -75.0% |
| Q3 2018 | $921,000 | +254.2% | 24,241 | +321.8% | 0.06% | +366.7% |
| Q2 2018 | $260,000 | +4.8% | 5,747 | +12.0% | 0.01% | -7.7% |
| Q1 2018 | $248,000 | -30.3% | 5,132 | -55.2% | 0.01% | -27.8% |
| Q3 2017 | $356,000 | – | 11,450 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |